Exactech Celebrates 20 Years of Exactech Knee with Launch of New Real-Time Patient-Specific Solution in TKA
March 05 2014 - 10:00AM
Business Wire
Company to showcase new advanced surgical
technology at AAOS 2014 Annual Meeting
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone
and joint restoration products, commemorates the twentieth
anniversary of its knee system with the launch of ExactechGPS®
Guided Personalized Surgery, the first advanced surgical technology
to provide orthopaedic surgeons with a truly real-time
patient-specific solution in total knee arthroplasty.
As a pioneer of knee replacement, Exactech used its surgeon- and
engineer-driven principles to merge sophisticated technology with
innovative instrumentation, offering surgeons real-time control for
total knee arthroplasty. With an easy-to-read graphical interface
on a touch screen in the sterile field and streamlined operative
flow, ExactechGPS allows surgeons to fully understand the knee
anatomy through instantaneous data and imaging, which can be an
invaluable reference in their decisions regarding bone removal and
where to position the implant based on the anatomical structure of
the patient.
“ExactechGPS introduces a new concept that offers surgeons the
benefits of a patient-specific solution in total knee replacement
with the precision and accuracy of navigation, creating a new space
in the market for advanced surgical technologies,” Exactech
President David Petty said. “Through early clinical evaluations,
surgeons who use conventional instrumentation and those who use
advanced surgical technologies have had remarkable response and
positive results.”
ExactechGPS supports a wide array of soft tissue strategies,
ligament balancing options and less invasive approaches and
techniques. Through mechanical testing, ExactechGPS has
demonstrated a high level of accuracy and precision to within one
degree and one millimeter of variability.1 Medical literature
documents the importance of precise implant alignment for implant
longevity.2
At the 2014 American Academy of Orthopaedic Surgeons annual
meeting, Exactech will also introduce a patented real-time guide,
which allows for simple positioning of the femoral resection
through a single, navigated device.
“Twenty years ago, Exactech made a commitment to develop a
comprehensive knee system that would meet the wide range of total
knee replacement patients,” Petty said. “With this exciting launch,
Exactech showcases its investment in providing innovative solutions
to better patient outcomes.”
The launch coincides with the twentieth anniversary of the
Exactech Knee system — a system that has been recognized for
delivering performance over time1 with proven, time-tested design,
proprietary net compression molded polyethylene and excellent
long-term implant survivorship and clinical outcomes.1
Some of the highlights of the Exactech Knee system:
- Strong four-decade design lineage with
roots beginning with the Total Condylar and Insall/Burstein
knees.
- Excellent long-term clinical outcomes,
including 97.2 to 98.6 percent documented implant survival
rates.1
- Proprietary net compression molded
polyethylene inserts maintain oxidation resistance and fracture
toughness and have demonstrated excellent wear
characteristics.1
- Patented design offers improved
congruency and patella tracking and a tibial tray locking mechanism
that reduces insert motion and disassociation.1
- Optetrak Logic PS removes 30 percent
less bone than a traditional notch resection and is designed to
maximize stability and range of motion while providing surgeons
with an easier, faster and more consistent notch preparation.1
- Optetrak Logic CR offers a unique
surgical technique and implant system to maintain the anatomical
integrity of the posterior cruciate ligament. A selection of CR
Slope® inserts allows surgeons to easily balance flexion-extension
gaps.
- Optetrak Logic PS Constrained and CR
Constrained inserts allow surgeons to easily transition
intra-operatively to an increased constraint insert without
additional bone preparation.
- Low Profile Instrumentation features
user-friendly instruments and a modular case design for greater
efficiencies in the O.R.
Live demos of the ExactechGPS technology will be held next
Wednesday, March 12, through Friday, March 14, at Exactech’s Booth
#2261 during the AAOS 2014 Annual Meeting. More information about
this and other Exactech innovations is available at
www.exac.com/academy.
References:
1. Data on file at Exactech, Inc.
2. Ritter MA, Faris PM, Keating EM, Meding JB.
Postoperative alignment of total knee replacement: its effect on
survival. Clin Orthop Relat Res. 1994; 299: 153-156
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, in addition to more than 30
markets in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech, Inc. can be found at
http://www.exac.com. Copies of Exactech’s press releases, SEC
filings, current price quotes and other valuable information for
investors may be found at http://www.exac.com and
http://www.hawkassociates.com.
An investment profile on Exactech may be found at
http://www.hawkassociates.com/profile/exac.cfm. To receive future
releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
Exactech, Inc.Investor contactsJody Phillips, 352-377-1140Chief
Financial OfficerorHawk AssociatesJulie Marshall or Frank Hawkins,
305-451-1888E-mail: exactech@hawkassociates.com
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Apr 2023 to Apr 2024